Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,491,381
-
Share change
-
-469,012
-
Total reported value
-
$24,260,162
-
Put/Call ratio
-
430%
-
Price per share
-
$9.74
-
Number of holders
-
58
-
Value change
-
-$4,267,020
-
Number of buys
-
25
-
Number of sells
-
35
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q2 2018
As of 30 Jun 2018,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,491,381 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Pennsylvania Trust Co, SUSQUEHANNA INTERNATIONAL GROUP, LLP, HighTower Advisors, LLC, BlueCrest Capital Management Ltd, Marshall Wace North America L.P., GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY.
This page lists
58
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.